#GI25 @RenoHemonc on the🙋🏻‍♂️of accelerated approval in neoadjuvant setting,➡️randomized trial first.

From the excellent work by @JenSeligmann FOXTROT💃trial, we know what chemo can do - response/DFS.

💡So we have the ingredients of what the trial should look like. @OncoAlert